Methods of using Ajoene for inhibiting integrin-mediated cell-cell fusion

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5981602
SERIAL NO

08584038

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of ajoene for inhibiting integrin-mediated cell-cell fusion. Specific types of cell-cell fusion are giant multinucleated cell formation, syneytia formation, and osteoclast formation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BILLINGS PHARMACEUTICAL INC2440 N LAKEVIEW AVE CHICAGO IL 60614

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Davidson, John B 2440 N. Lakeview Ave., Chicago, IL 60614 42 467
Tatarintsev, Alexander V Moscow, RU 10 34
Turgiev, Ali S Moscow, RU 11 29

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation